[PDF][PDF] Renal Biomarkers N-Acetyl-Beta-D-Glucosaminidase (NAG), Endothelin, and Their Application

S Çuhadar, T Semerci - Biomark. Kidney Dis, 2016 - researchgate.net
The risk of acute kidney injury is rising due to aging in the world and with the increased
usage of therapeutic agents and diagnostic interventions which are highly nephrotoxic …

[HTML][HTML] Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - Bioengineering, 2023 - mdpi.com
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

Study of Urinary N-Acetyl-Beta-D-Glucosaminidase as a biomarker of Diabetic Nephropathy

AA Mahmoud, NM Mostafa, O Mesbah… - … Egyptian Journal of …, 2021 - ejhm.journals.ekb.eg
Background: Diabetic nephropathy (DN) is a major cause of morbidity and mortality in
diabetic patients worldwide. Plenty of tubular damage biomarkers have been discovered …

[PDF][PDF] The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment

S Skálová - ACTA MEDICA-HRADEC KRALOVE-, 2005 - researchgate.net
The kidney function can be assessed by a number of methods. The urinary excretion of
enzymes, in particular N-acetyl-β-D-glucosaminidase (NAG), is considered a relatively …

[HTML][HTML] The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the …

SR Kim, Y Lee, SG Lee, ES Kang, BS Cha… - Cardiovascular …, 2017 - Springer
Background To determine the association between urinary N-acetyl-β-d-glucosaminidase
(NAG), a marker of renal tubulopathy, and carotid intima-media thickness (IMT) and plaques …

N‐acetyl‐b‐D‐glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality

R Allgaier, C Strack, S Wallner, U Hubauer… - …, 2020 - Wiley Online Library
Aims Chronic heart failure may lead to chronic kidney disease. Previous studies suggest
tubular markers N‐acetyl‐b‐D‐glucosaminidase (NAG) and Kidney‐injury‐molecule‐1 (KIM …

Biochemical markers of renal function

D Krstic, N Tomic, B Radosavljevic… - Current medicinal …, 2016 - ingentaconnect.com
Kidney damage can be induced by ischemia, autoimmune diseases, hypertension, allograft
rejection, metabolic or genetic disorders, infections or toxins. The influence of these factors …

Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury

Z Abassi, O Sagi, Z Armaly, B Bishara - Harefuah, 2011 - europepmc.org
The incidence of both acute and chronic kidney diseases is persistently increasing and is
reaching epidemic proportions. Early therapeutic intervention may significantly decrease the …

N‐acety‐b‐D‐glucosaminidase: a potential biomarker for early detection of acute kidney injury in acute chest pain

M Kaufmann, M Schlossbauer, U Hubauer… - …, 2020 - Wiley Online Library
Aim Acute kidney injury (AKI) is often underdiagnosed due to several limitations of the renal
marker creatinine. Tubular urinary biomarkers may substantially contribute to diagnose AKI …

The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease

K Chaudhary, G Phadke, R Nistala… - Current diabetes …, 2010 - Springer
Currently used measures to assess kidney function and injury are largely inadequate.
Markers such as serum creatinine, formulas to estimate glomerular filtration rate, cystatin C …